A Single-Dose Crossover Oral Bioequivalence Study of PL 3100 and Naproxen in Healthy Adult Volunteers in the Fasted State.
Phase of Trial: Phase I/II
Latest Information Update: 10 Sep 2015
At a glance
- Drugs Naproxen (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors PLx Pharma
- 13 May 2010 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 13 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Sep 2009 New trial record